Vitamin E from Rapeseed Offers Non-Soy Alternative
Nutralliance’s new RavEtol is a non-GMO and non-soy vitamin E ingredient.
Photo © iStockphoto.com/timsa
Nutralliance (Yorba Linda, CA) has announced plans to expand on the market for non-soy tocopherol ingredients with the launch of RavEtol, a vitamin E ingredient derived from rapeseed (Brassica napus) oil.
Compared to vitamin E derived from soy, rapeseed offers vitamin E with a similar tocopherol value but a higher alpha content, says Nutralliance. To the best of the company’s knowledge, RavEtol is the only rapeseed-derived vitamin E ingredient on the North American market.
The new RavEtol joins Nutralliance’s existing line of non-GMO vitamin E products, including alpha tocopherol, mixed tocopherols, and plant sterols, which are available in the United States in collaboration with Advanced Organic Materials (AOM; Argentina).
“We are very proud of our entire natural, non-GMO E line with AOM, but the addition of RavEtol has us more excited than ever about the advantage we’re able to offer our customers,” said Brian Salerno, president and CEO, Nutralliance. “Clean labeling is a key consideration for formulators and product developers–particularly when it comes to natural non-GMO and non-soy ingredients.”
RaveEtol is available in oil and powder formulas, says Nutralliance.
Read more:
Vitamin E's Alternative Sources
Michael Crane
Associate Editor
Nutritional Outlook Magazine
michael.crane@ubm.com
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
